{"paper_id":"afad18e3-8812-49ac-9a01-6f19dfe1cac2","body_text":"Abstract\nPurpose\nTo investigate Asherman syndrome (AS) related to potential factors during uterine artery embolization (UAE) treatment of adenomyosis.\nMaterials and methods\nThis is a retrospective analysis of 195 women with adenomyosis who underwent UAE treatment from 2009 to 2016. All preoperative and intraoperative risk-related potential factors of AS were recorded. And AS events were carefully monitored during follow-up (range, 0–15 months). Potential risk-related factors of AS events were determined via univariate and multivariate logistic regression analyses.\nResults\nThe rate of AS events after UAE for adenomyosis was 12.82% (25/195). The univariate and multivariate analyses revealed the association of low vascularity with a significant risk for AS (P = 0.019).\nConclusion\nPatients with low vascularity of adenomyosis at the time of UAE are more likely to have AS. And adenomyosis patients with low vascularity should be carefully selected to undergo UAE treatment.\nSimilar content being viewed by others\nReferences\nKim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, Cho JH, Cha SH (2012) Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 188:176\nSmeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HA, van Rooij WJ, Lohle PN (2012) Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol 35:815–819\nBratby MJ, Walker WJ (2009) Uterine artery embolisation for symptomatic adenomyosis-mid-term results. Eur J Radiol 70:128–132\nPelage JP, Jacob D, Fazel A, Namur J, Laurent A, Rymer R, Le Dref O (2005) Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 234:948–953\nTropeano G, Amoroso S, Di Stasi C et al (2014) Incidence and predictive factors for complications after uterine leiomyoma embolization. Hum Reprod 29:1918–1924\nMoss JG, Cooper KG, Khaund A et al (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. Int J Obstet Gynaecol 118:936–944\nHolub Z, Mara M, Kuzel D et al (2008) Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. Fertil Steril 90(5):0–1891\nMara M, Kubinova K, Maskova J (2012) Uterine artery embolization versus laparoscopic uterine artery occlusion: the outcomes of a prospective nonrandomized clinical trial. Cardiovasc Int Radiol 35(5):1041–1052\nGoldberg J, Pereira L, Berghella V et al (2004) Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191(1):18–21\nWalker WJ, Mcdowell SJ (2006) Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol 195(5):1266–1271\nDe Bruijn AM, Smink M, Lohle PNM et al (2017) Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Int Radiol 28(12):1629–1642\nSong D, Liu Y, Xiao Y, Li TC, Zhou F, Xia E (2014) A matched cohort study comparing the outcome of intrauterine adhesiolysis for asherman syndrome after uterine artery embolization or surgical trauma. J Minim Invasive Gynecol 21:1022–1028\nSpies JB, Spector A, Roth AR et al (2002) Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 100(5):873–880\nAhmad A, Qadan L, Hassan N et al (2002) Uterine artery embolization for treatment of uterine fibroids: effect on ovarian function in younger women. J Vasc Interv Radiol 13(10):1017–1020\nLanciego C, Diazplaza I, Ciampi JuanJosé et al (2012) Utero-ovarian Anastomoses and Their Influence on Uterine Fibroid Embolization. J Vasc Int Radiol 23(5):595–601\nRashid S, Khaund A, Murray LS et al (2010) The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. Bjog An Int J Obstet Gynaecol 117(8):985–989\nMara M, Fucikova Z, Kuzel D et al (2007) Hysteroscopy after uterine fibroid embolization in women of fertile age. Obstet Gynaecol Res 33:316–324\nMara M, Horak P, Kubinova K et al (2012) Hysteroscopy after uterine fibroid embolization: evaluation of intrauterine findings in 127 patients. Obstet Gynaecol Res 38:823–831\nChen CL, Xu YJ, Liu P et al (2013) Characteristics of vascular supply to uterine leiomyoma: an analysis of digital subtraction angiography imaging in 518 cases. Eur Radiol 23(3):774–779\nYixin T, Chunlin C, Hui D et al (2016) Low vascularity predicts favourable outcomes in leiomyoma patients treated with uterine artery embolization. Eur Radiol 26(10):1–9\nZhou J, He L, Liu P et al (2016) Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases. PLoS ONE 11(11):e0165610\nListed NA (1988) The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril 49(6):944\nGuo SW (2018) Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? Hum Reprod Update 24:1–22\nLohle PNM, Higué D (2019) Uterine artery embolisation in women with symptomatic adenomyosis. Presse Med 48:435–439\nde Bruijn AM, Smink M, Hehenkamp WJK et al (2017) Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire. Cardiovasc Intervent Radiol 40:1344–1350\nDessouky R, Gamil SA, Nada MG et al (2019) Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging 10:48\nIsonishi S, Coleman RL, Hirama M et al (2008) Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization. Am J Obstet Gynecol 198(3):270e1–270e6\nKim MD, Lee M, Jung DC et al (2012) Limited efficacy of uterine artery embolization for cervical leiomyomas. J Vasc Interv Radiol 23(2):236–240\nZhou S, Yi T, Liu R et al (2012) Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol Cell Proteomics Mcp 11:3929–3936\nKitamura Y, Allison SJ, Jha RC, Spies JB, Flick PA, Ascher SM (2006) MRI of adenomyosis: changes with uterine artery embolization. AJR Am J Roentgenol 186:855–864\nPark Y, Man DK, Jung DC et al (2015) Can measurement of apparent diffusion coefficient before treatment predict the response to uterine artery embolization for adenomyosis? Eur Radiol 25:1303–1309\nJung DC, Kim MD, Oh YT, Won JY, Lee DY (2012) Prediction of early response to uterine arterial embolisation of adenomyosis:value of T2 signal intensity ratio of adenomyosis. Eur Radiol 22:2044–2049\nLee CC, Reardon MA, Ball BZ et al (2015) The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. J Neurosurg 123:136–144\nDundr P, Mára M, Masková J, Fucíková Z, Povỳsil C, Tvrdík D (2006) Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization. Pathol Res Pract 202:721–729\nDiscepola F, Valenti DA, Reinhold C (2007) Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol 110:1301–1303\nSpeir E, Shekhani H, Peters G (2017) Temporary anorgasmia following uterine artery embolization for symptomatic uterine fibroids. Cardiovasc Intervent Radiol 40:1–4\nBilhim T, Pisco JM (2010) The role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the management of the post-embolization symptoms after uterine artery embolization. Pharmaceuticals 3:1729–1738\nZheng R, Zeng D, Wan TT et al (2018) Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis. Diagn Interv Radiol 24:364–371\nChen Y, Liu L, Luo Y, Chen M, Huan Y, Fang R (2016) Prevalence and impact of chronic endometritis in patients with intrauterine adhesions:a prospective cohort study. J Minim Invasive Gynecol 24:74–79\nDalton VK, Saunders NA, Harris LH, Williams JA, Lebovic DI (2006) Intrauterine adhesions after manual vacuum aspiration for early pregnancy failure. Fertil Steril 85:1823(e1–3)\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEthics declarations\nConflict of interest\nThe authors declare that they have no conflict of interest.\nConsent for publication\nConsent for publication was obtained for every individual person’s data included in the study.\nEthical approval\nAll procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975.\nInformed consent\nInformed consent was obtained from all individual participants included in the study.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nAbout this article\nCite this article\nWang, Y., Lyu, W., Xu, W. et al. Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors. Radiol med 125, 437–443 (2020). https://doi.org/10.1007/s11547-020-01136-8\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s11547-020-01136-8","source_license":"CC0","license_restricted":false}